Merck Ventures
Finance · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18 Hakishon St, Yavne, Central District,...Phone Number
(408) 600-8138Website
www.m-ventures.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Merck Ventures
M Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact the company's core business areas. From its headquarters in Amsterdam and offices in the US and Israel, M Ventures invests globally in transformational ideas driven by great entrepreneurs. M Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. M Ventures has a significant focus on early stage investing and company creation including the creation of spin-offs to leverage the company's science and technology base.Explore more
Merck Ventures Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Merck Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Merck Ventures had a recent Job posting/layoffs
Earning: See what the market has to say on Merck Ventures recently announced quarterly report
Check if Merck Ventures has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Merck Ventures launches new products
Website visits: Recent activity has been detected on your website
Check out if Merck Ventures is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Merck Ventures
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Merck Ventures has new funding data
Merck Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Merck Ventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Merck Ventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Merck Ventures.
Merck Ventures Tech Stack
A closer look at the technologies used by Merck Ventures
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Merck Ventures News & Media
Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy
Series A co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital with syndicate including Bioqube Ventures, Surveyor Capital and others Led by founder and drug discovery expert Dr. Andreas Goutopoulos, Actithera's proprietary...NovoLINC Secures Investments to Assist AI Computing with Groundbreaking Thermal Interface Technology
PITTSBURGH, Jan. 21, 2025 /PRNewswire/ -- NovoLINC, a thermal technology startup spun out of Carnegie Mellon University, announced seed funding led by M Ventures, with participation from Foothill Ventures and TDK Ventures. NovoLINC's breakthrough nanocomposite thermal solutions reduce...Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®
Oxford, United Kingdom – October 3, 2024. Enara Bio today announces the closing of a $32.5 million Series B financing supported by a strong syndicate of new and existing biotech investors. The round was co-led by new investors, Pfizer Ventures and M Ventures, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health Investors. The Francis Crick Institute is also joining the round as a new investor. Enara Bio will use
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Merck Ventures
Sign Up For FreeTo access detailed company insights
M Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact the company's core business areas. From its headquarters in Amsterdam and offices in the US and Israel, M Ventures invests globally in transformational ideas driven by great... Read More
